Trial intelligence / Profile preview

Colchicine nanofibers for recurrent aphthous ulceration

IRCT20160920029889N4Phase 2Completed

Sponsor
Mazandaran University of Medical Sciences
Start
Jan 2023
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, open-label trial of colchicine and triamcinolone in aphthosis (RAS) (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoints: Lesion size, Pain and 1 more. Started Jan 2023; status: completed.

02

Drugs

colchicinetriamcinolone
03

Conditions

aphthosis (RAS)

Beyond the preview

Go deeper on IRCT20160920029889N4.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20160920029889N4.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call